Mallinckrodt plc
Case Number:
1:20-bk-12522
Court:
Nature of Suit:
Firms
- Abernathy Roeder
- Abrams & Bayliss
- Akin Gump
- Andrews & Thornton
- ArentFox Schiff
- Arnold & Porter
- Ashby & Geddes
- ASK LLP
- Bailey & Glasser
- Barrack Rodos
- Bartimus Frickleton
- Beasley Firm
- Benesch
- Berger Harris
- Bielli & Klauder
- Bilzin Sumberg
- Binder & Schwartz
- Blank Rome
- Bragar Eagel
- Brown & Connery
- Brown Rudnick
- Buchalter APC
- Campbell & Levine
- Caplin & Drysdale
- Carlton Fields
- Carothers & Hauswirth
- Chamberlain Hrdlicka
- Chiesa Shahinian
- Chipman Brown
- Ciardi Ciardi
- Clark Hill
- Cole Schotz
- Connolly Gallagher
- Consovoy McCarthy
- Cooch & Taylor
- Cooley LLP
- Covington & Burling
- Cozen O'Connor
- Cross & Simon
- Crowell & Moring
- David Christian Attorneys LLC
- Dechert LLP
- Dentons
- DLA Piper
- Doroshow Pasquale
- Dorsey & Semrau
- Duane Morris
- Eimer Stahl
- Eiseman Levine
- Elliott Greenleaf
- Faegre Drinker
- Finson Law Firm
- Fishman Haygood
- Flaster Greenberg
- Foley & Lardner
- Fox Rothschild
- Fox Swibel
- FrankelWyron
- FrankGecker
- Frazer PLC
- Friedman Kaplan
- Gellert Scali
- Gibson Dunn
- Gilbert LLP
- Goldstein & McClintock
- Goodwin Procter
- GrayRobinson
- Greenberg Traurig
- Hackett Feinberg
- Hagens Berman
- Halperin Battaglia
- Haviland Hughes
- Henrichsen Law Group
- Herrick Feinstein
- Hobbs Straus
- Hogan McDaniel
- Hughes Socol
- Hunton Andrews
- Jenner & Block
- Jones Day
- Katten Muchin
- Kay Casto
- Keller Postman
- Kennedys Law LLP
- Klehr Harrison
- Kleinberg Kaplan
- K&L Gates
- Kobre & Kim
- Kramer Levin
- Landis Rath
- Latham & Watkins
- Lathrop GPM
- Law Office of Curtis A. Hehn
- Leader Berkon
- Leech Tishman
- Levenfeld Pearlstein
- Lewis Brisbois
- Linebarger Goggan
- Lippes Mathias
- Locke Lord
- Loeb & Loeb
- Lowenstein Sandler
- Lowey Dannenberg
- MacElree Harvey
- Margolis Edelstein
- Martzell Bickford
- Maschoff Brennan
- McCarter & English
- McDermott Will & Emery
- McGivney Kluger
- McLaughlin Law Office
- Mehri & Skalet
- Meyers & Flowers
- Michael Best & Friedrich LLP
- Miller & Martin
- Miller Nash LLP
- Montgomery McCracken
- Monzack Mersky
- Morgan Lewis
- Morris James
- Morris Nichols
- Moses & Singer
- Motley Rice
- Munsch Hardt
- Napoli Shkolnik
- Norton Rose
- Obermayer Rebmann
- Ogletree Deakins
- O'Melveny & Myers
- Pachulski Stang
- Parkowski Guerke
- Paul Hastings
- Paul Weiss
- Perdue Brandon
- Phillips Lytle
- Potter Anderson
- Powell Firm
- Pryor Cashman
- Quinn Emanuel
- Reed Smith
- Richards Layton
- Robbins Geller
- Robbins Russell
- Robinson & Cole
- Rolnick Kramer
- Rosner Law Group LLC
- Ross Aronstam
- Ross Smith & Binford
- Saul Ewing
- Schulte Roth
- Sequor Law
- Seward & Kissel
- Sherrard Roe
- Shipman & Goodwin
- Simon Greenstone
- Singer & Levick
- Sirlin Lesser
- Skadden Arps
- Skikos Crawford
- Smith Katzenstein
- Sonosky Chambers
- Stevens & Lee
- Stradley Ronon
- Stutzman Bromberg
- Sullivan & Cromwell
- Sullivan Hazeltine
- Sussman Shank
- Taft Stettinius
- The Cooper Law Firm
- Togut Segal
- Troutman Pepper
- Wachtell Lipton
- Warner Norcross
- White & Case
- Whiteford Taylor
- Willkie Farr
- WilmerHale
- Wilson Sonsini
- Womble Bond
- Young Conaway
Companies
- Aetna Inc.
- AlixPartners LLP
- Allianz Global Investors GmbH
- American Federation of State County & Municipal Employees
- Anda Inc.
- ASM Capital LP
- Berkshire Hathaway Inc.
- Bristol-Myers Squibb Co.
- Callidus Software Inc.
- Cardinal Health Inc.
- Catalent Inc.
- Cencora Inc.
- Cephalon Inc.
- CNA Financial Corp.
- Concur Technologies, Inc.
- Conduent Inc.
- Constellation Energy Corp.
- Cornerstone Research Inc.
- Covance Inc.
- Covidien PLC
- CSX Corp.
- CVS Health Corp.
- Deloitte Touche Tohmatsu Ltd.
- Deutsche Bank AG
- Ducera Partners LLC
- Duke Energy Corp.
- Endo International PLC
- Ernst & Young LLP
- Express Scripts Holding Co.
- Ferguson Enterprises Inc.
- Fresenius Kabi AG
- Guggenheim Partners LLC
- HealthCor Partners Management LP
- Henry Schein Inc.
- Humana Inc.
- Integrated Benefits Inc.
- Iqvia Holdings Inc.
- Iron Mountain Inc.
- Ironshore Inc.
- Jefferies Financial Group Inc.
- Johnson Controls International PLC
- Johnson & Johnson
- JPMorgan Chase & Co.
- Liberty Mutual Insurance Group
- LifeWallet
- Lumen Technologies Inc.
- McKesson Corp.
- Medco Health Solutions Inc.
- Microsoft Corp.
- Morgan Stanley
- New York State Electric & Gas Corp.
- Old Dominion Freight Line Inc.
- Olin Corp.
- Optum Inc.
- OptumRx Inc.
- Oracle Corp.
- Paulson & Co. Inc.
- PCI Pharma Services
- Perrigo Co. PLC
- Province LLC
- Quantitative Investment Management LLC
- Rain for Rent Inc.
- SAP AG
- Southeastern Freight Lines Inc.
- State Teachers Retirement System of Ohio
- Stretto Inc.
- Teva Pharmaceutical Industries Ltd.
- The Goldman Sachs Group Inc.
- Third Point LLC
- United Association
- United BioSource Corp.
- University of Iowa
- University of Toledo
- U.S. Bancorp
- Wells Fargo & Co.
Government Agencies
- City of Syracuse, New York
- Minnesota Department of Revenue
- Mississippi Division of Medicaid
- Missouri Department of Revenue
- Ohio Department of Taxation
- State of Indiana
- State of Michigan
- Texas Comptroller of Public Accounts
- Texas Workforce Commission
Sectors & Industries:
-
October 14, 2022
Alex Jones' Billion-Dollar Penance, Puerto Rico Prunes Debt
Conspiracy theorist Alex Jones' podcast company is headed toward Chapter 11 mediation after a $965 million defamation damages judgment, Puerto Rico takes another step in restructuring the island's public debt, and the U.S. Supreme Court remanded issues over an increase in trustee fees to the Second Circuit. This is the week in bankruptcy.
-
October 13, 2022
Mallinckrodt Ch. 11 Trustee Settles Acthar Royalty Claims
The trustee administering the claims of general unsecured creditors under the confirmed plan of drugmaker Mallinckrodt PLC asked a Delaware bankruptcy court for approval Wednesday of a settlement that would resolve royalty claims associated with the company's Acthar gel.
-
June 08, 2022
Costlier Loans Clear Mallinckrodt For Ch. 11 Exit Next Week
Bankrupt drugmaker Mallinckrodt PLC reported Wednesday that its Chapter 11 plan would most likely take effect on June 14, after the eleventh-hour approval of a $650 million exit financing package that replaced — at much higher cost — a $900 million exit financing agreement.
-
May 23, 2022
Mallinckrodt Calls Shareholder Ch. 11 Stay Bid Untimely
Drugmaker Mallinckrodt PLC objected Monday to a motion from an equity holder seeking to stay the consummation of the company's Chapter 11 plan pending the outcome of an appeal of a claims bar date decision, saying the stay motion came months late and after other, more targeted stay requests were defeated.
-
April 25, 2022
Mallinckrodt Creditors Can't Get Ch. 11 Plan Halted
Unsecured creditors of drugmaker Mallinckrodt PLC have lost their bid to delay the effective date of the company's Chapter 11 plan in Delaware federal court, with a Third Circuit judge saying the creditors had not shown they would be irreparably harmed if the plan is consummated.
-
March 24, 2022
Mallinckrodt Creditor Payments Won't Be Held For Appeals
A Delaware bankruptcy judge Thursday denied requests to hold distributions from drugmaker Mallinckrodt's Chapter 11 plan while appeals of how the funds are being divided up are pending, saying it is likely the appeals will be heard before the money goes out.
-
March 01, 2022
Acthar Claimants Seek End To Mallinckrodt Litigation Pause
A group of Acthar gel tort claimants asked a Delaware bankruptcy judge on Tuesday to reject a request by Mallinckrodt to continue an order pausing Acthar suits, saying there is no longer a "legal or practical" reason to hold up their claims against a third party.
-
February 14, 2022
Mallinckrodt Seeks Last Extension Of Ch. 11 Acthar Suit Pause
Mallinckrodt PLC is asking a Delaware bankruptcy judge for one final extension of an order pausing lawsuits against the drugmaker relating to its marketing of Acthar gel products, saying it needs the injunction to see it through to the end of its Chapter 11 case.
-
February 04, 2022
Mallinckrodt Ch. 11 Plan Gets Green Light From Del. Court
A Delaware federal bankruptcy court on Thursday confirmed Mallinckrodt PLC's Chapter 11 plan, which the drugmaker said reduces the company's total debt by approximately $1.3 billion.
-
January 25, 2022
Mallinckrodt, Fresenius Reach $14M Deal On Supply Claims
Drugmaker Mallinckrodt PLC is asking a Delaware bankruptcy judge to approve a $13.9 million settlement with a subsidiary of German pharmaceutical company Fresenius Kabi to end a dispute over supply payments Mallinckrodt cut off when it entered Chapter 11.